How biosimilars will impact costs and care in oncology.
Publication
, Journal Article
Lyman, GH
Published in: Clin Adv Hematol Oncol
October 2019
Duke Scholars
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
October 2019
Volume
17
Issue
10
Start / End Page
544 / 547
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms
- Interviews as Topic
- Humans
- Drug Costs
- Biosimilar Pharmaceuticals
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H. (2019). How biosimilars will impact costs and care in oncology. Clin Adv Hematol Oncol, 17(10), 544–547.
Lyman, Gary H. “How biosimilars will impact costs and care in oncology.” Clin Adv Hematol Oncol 17, no. 10 (October 2019): 544–47.
Lyman GH. How biosimilars will impact costs and care in oncology. Clin Adv Hematol Oncol. 2019 Oct;17(10):544–7.
Lyman, Gary H. “How biosimilars will impact costs and care in oncology.” Clin Adv Hematol Oncol, vol. 17, no. 10, Oct. 2019, pp. 544–47.
Lyman GH. How biosimilars will impact costs and care in oncology. Clin Adv Hematol Oncol. 2019 Oct;17(10):544–547.
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
October 2019
Volume
17
Issue
10
Start / End Page
544 / 547
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms
- Interviews as Topic
- Humans
- Drug Costs
- Biosimilar Pharmaceuticals